Citation: B. Lind et al., Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain, BR J HAEM, 113(3), 2001, pp. 642-648
Citation: M. Philips et al., Characterization of a complex between active plasminogen activator inhibitor-1 and N-terminal fragments of vitronectin from human placenta, FIBRINOL PR, 14(1), 2000, pp. 22-34
Citation: K. Bangert et S. Thorsen, Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis, THROMB HAEM, 84(2), 2000, pp. 299-306
Authors:
Frikke-Schmidt, R
Arlien-Soborg, P
Thorsen, S
Jensen, HK
Vorstrup, S
Citation: R. Frikke-schmidt et al., LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are, EUR J NEUR, 6(6), 1999, pp. 691-696
Citation: B. Lind et S. Thorsen, A novel missense mutation in the human plasmin inhibitor (alpha(2)-antiplasmin) gene associated with a bleeding tendency, BR J HAEM, 107(2), 1999, pp. 317-322